Sign up Australia
Proactive Investors - Run By Investors For Investors

The Hydroponics Company’s shares surge after signing medicinal cannabis deal

Initial products imported to Australia will include cannabidiol oil.
cannabis cultivation
Recently granted a medicinal cannabis licence

The Hydroponics Company Ltd’s (ASX:THC) subsidiary, Canndeo Ltd, has signed a distribution agreement with Endoca B.V. to distribute medicinal cannabis products into Australia.

Endoca is one of Europe’s most highly respected suppliers of GMP (Good Manufacturing Practice) certified medicinal cannabis, with sales exceeding €50 million per annum.

Initial products imported to Australia will include CBD (cannabidiol) oil, CBD capsules and a unique CBD + CBDA (cannabidiolic acid) oil.

The Hydroponics Company’s shares were last trading 59% higher intra-day, at $0.835.

Focus on rapid commercialisation

Canndeo Ltd was recently granted a medicinal cannabis licence by the Office of Drug Control, Australia that authorises the cultivation and growth of cannabis plants for medicinal purposes.

READ NEXT: The Hydroponics Company granted Medicinal Cannabis Licence

Obtaining the licence meets one of Canndeo’s key milestones on the path to its goal – the commercial cultivation of medicinal cannabis in Australia.

This is the second of three licences approved, with the company having lodged a manufacturing licence and is awaiting approval.

Significant step forward in distributing high quality medicinal cannabis

The agreement with Endoca provides a solid platform to expand the company’s activities including its focus on rapid commercialisation.

It is a significant step forward in distributing high quality medicinal cannabis products through European pioneers in extraction and purification.

David Radford, chief executive officer, commented: “The distribution agreement with Endoca is an important milestone for THC and Canndeo in its program to deliver medicinal cannabis solutions into Australia.

“We are very pleased that Endoca recognises Canndeo as the right partner for distributing medicinal cannabis solutions and we look forward to developing this relationship as more Australian doctors and patients seek a positive way forward with medicinal cannabis.”

Join our Crypto, Blockchain and Cannabis Telegram group here
View full THC profile View Profile

Hydroponics Company Ltd Timeline

Related Articles

Picture of growing facility
May 07 2018
Establishing a vertically integrated business model provides THC with the ability to optimise efficiencies in the manufacturing process.
scientist in lab
September 25 2018
VAL401 is ValiRx’s most advanced compound, with earlier trial results suggesting it can improve quality of life and chances of survival of lung cancer patients
1537236236_main-better-use.jpg
September 18 2018
The company is utilising technology and big data to tackle the growing healthcare crisis and personalise treatment options for preventative care.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use